Idioma:

Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl

Spósito, Andrei C ; Caramelli, Bruno ; Serrano, Carlos V ; Mansur, Antonio P ; Ramires, Jose A.F

The American journal of cardiology, 1999, Vol.83 (1), p.98-100 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl
Autor: Spósito, Andrei C ; Caramelli, Bruno ; Serrano, Carlos V ; Mansur, Antonio P ; Ramires, Jose A.F
Assuntos: Anticholesteremic Agents - administration & dosage ; Anticholesteremic Agents - therapeutic use ; Cholesterol, HDL - blood ; Clofibric Acid - administration & dosage ; Clofibric Acid - analogs & derivatives ; Clofibric Acid - therapeutic use ; Coronary Disease - blood ; Coronary Disease - drug therapy ; Delayed-Action Preparations ; Drug Administration Schedule ; Drug Synergism ; Female ; Humans ; Lipids - blood ; Male ; Middle Aged ; Niacin - administration & dosage ; Niacin - therapeutic use ; Time Factors ; Treatment Outcome
É parte de: The American journal of cardiology, 1999, Vol.83 (1), p.98-100
Descrição: Niacin treatment (alone) was compared with etofibrate and niacin combination to treat patients with high-density lipoprotein <35 mg/dl and without hypertriglyceridemia. The niacin and etofibrate combination proved to be safe and increased high-density lipoprotein cholesterol levels to 48%, which was 3 times higher than that obtained with niacin alone.
Editor: United States: Elsevier Inc
Idioma: Inglês

Links

Voltar para lista de resultados